SKI Market

Indian Indices

Sensex

81,287.19 -961.42
( -1.17%)

Global Indices

Nasdaq

49,510.83 7.68
(0.02%)

Dow Jones

6,928.66 -38.47
(-0.55%)

Hang Seng

58,843.60 90.21
(0.15%)

Nikkei 225

10,926.32 79.62
(0.73%)

Forex

USD-INR

90.92 -0.01
(-0.01%)

EUR-INR

107.23 0.12
(0.12%)

GBP-INR

122.98 0.28
(0.22%)

JPY-INR

0.58 0.00
(-0.40%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Procter & Gamble Health Ltd

Industry : Pharmaceuticals - Multinational

BSE Code

ISIN Demat

Book Value()

500126

INE199A01012

373.3448522

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

PGHL

29.01

8513.74

EPS(TTM)

Face Value()

Div & Yield %

176.81

2.44

Back

Procter & Gamble Health standalone net profit declines 14.64% in the December 2025 quarter

Feb 06,2026

Net profit of Procter & Gamble Health declined 14.64% to Rs 77.59 crore in the quarter ended December 2025 as against Rs 90.90 crore during the previous quarter ended December 2024. Sales rose 20.69% to Rs 373.86 crore in the quarter ended December 2025 as against Rs 309.77 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	373.86	309.77	21
OPM %	29.55	39.85	-
PBDT	114.72	127.24	-10
PBT	108.82	121.69	-11
NP	77.59	90.90	-15

81,287.19 -961.42 ( -1.17%)

49,510.83 7.68 (0.02%)

6,928.66 -38.47 (-0.55%)

58,843.60 90.21 (0.15%)

10,926.32 79.62 (0.73%)

90.92 -0.01 (-0.01%)

107.23 0.12 (0.12%)

122.98 0.28 (0.22%)

0.58 0.00 (-0.40%)